iTeos Therapeutics/$ITOS
About iTeos Therapeutics
Ticker
Industry
Employees
ITOS Metrics
$285M
-
-$3.14
1.39
-
Price and volume
Market cap
$285M
Beta
1.39
52-week high
$18.75
52-week low
$7.09
Average daily volume
471K
Financial strength
Current ratio
14.801
Quick ratio
14.438
Long term debt to equity
0.661
Total debt to equity
0.875
Management effectiveness
Return on assets (TTM)
-13.04%
Return on equity (TTM)
-19.72%
Valuation
Price to revenue (TTM)
8.608
Price to book
0.45
Price to tangible book (TTM)
0.45
Price to free cash flow (TTM)
-2.504
Growth
Revenue change (TTM)
-47.37%
Earnings per share change (TTM)
81.89%
3-year revenue growth (CAGR)
-30.50%
3-year earnings per share growth (CAGR)
99.06%
What the Analysts think about ITOS
Analyst Ratings
ITOS Financial Performance
Income Statement
Q3 24
QoQ growth
$37B
-39.75%
$45B
107.52%
37.65%
6.78%
ITOS Earnings Performance
Earnings per share (EPS)
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
$3.69
$2.85
$2.45
$2.42
-
$3.55
$2.61
$2.05
$2.31
$3.94
3.94%
9.20%
19.51%
4.63%
-
ITOS News
iTeos Therapeutics: A Perhaps Unjustified Decline To End 2024
iTeos Therapeutics Presents Interim A2A-005 Clinical Trial Data, Translational, and Preclinical Data from Inupadenant at ESMO Immuno-Oncology Congress
iTeos to Participate in Upcoming Investor Conferences
FAQs
What’s the current market cap for iTeos Therapeutics stock?
What is the P/E ratio for iTeos Therapeutics stock?
Does iTeos Therapeutics stock pay dividends?
No, iTeos Therapeutics (ITOS) stock does not pay dividends to its shareholders as of January 15, 2025.
When is the next iTeos Therapeutics dividend payment date?
iTeos Therapeutics (ITOS) stock does not pay dividends to its shareholders.
What is the beta indicator for iTeos Therapeutics?
iTeos Therapeutics (ITOS) has a beta rating of 1.39. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.